PNC Financial Services Group
SIOX

PNC Financial Services Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

PNC Financial Services Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-125
Closed -$54 – 4880
2022
Q4 		$54 Hold
125
– – ﹤0.01% 4721
2022
Q3 		$0 Hold
125
– – ﹤0.01% 4687
2022
Q2 		$0 Hold
125
– – ﹤0.01% 4825
2022
Q1 		$0 Hold
125
– – ﹤0.01% 4777
2021
Q4 		$0 Hold
125
– – ﹤0.01% 4689
2021
Q3 		$0 Hold
125
– – ﹤0.01% 4459
2021
Q2 		$0 Hold
125
– – ﹤0.01% 4327
2021
Q1 		$0 Hold
125
– – ﹤0.01% 4248
2020
Q4 		$0 Hold
125
– – ﹤0.01% 4114
2020
Q3 		$1K Hold
125
– – ﹤0.01% 3895
2020
Q2 		$0 Hold
125
– – ﹤0.01% 4099
2020
Q1 		$0 Hold
125
– – ﹤0.01% 4115
2019
Q4 		$1K Hold
125
– – ﹤0.01% 3924
2019
Q3 		$1K Hold
125
– – ﹤0.01% 3954
2019
Q2 		$1K Hold
125
– – ﹤0.01% 3974
2019
Q1 		$1K Hold
125
– – ﹤0.01% 3987
2018
Q4 		$1K Hold
125
– – ﹤0.01% 3998
2018
Q3 		$2K Buy
+125
New +$2.27K ﹤0.01% 3982
2018
Q1 		– Sell
-685
Closed -$29K – 4310
2017
Q4 		$29K Buy
+685
New +$30.7K ﹤0.01% 3223
2016
Q2 		– Sell
-13
Closed -$1K – 4569
2016
Q1 		$1K Buy
+13
New +$1.39K ﹤0.01% 4413

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

PNC Financial Services Group's SIOX Position: Q1 2023 in Review

PNC Financial Services Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 125 shares — an estimated $54 sold.

PNC Financial Services Group first reported a position in SIOX in Q1 2016 and held it in 20 quarters. The position peaked at $29K in Q4 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • PNC Financial Services Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 125 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $54.
  • PNC Financial Services Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2016 and held it in 20 quarters.
  • PNC Financial Services Group's Sio Gene Therapies Inc. Common Stock position peaked at $29K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.